THU0705-HPR PELVIC FLOOR AND SEXUAL DYSFUNCTION IN WOMEN WITH SJOGREN SYNDROME

Abstract

Background: Sjogren syndrome (SS) is a systemic autoimmune disease causing secretory gland dysfunction. This leads to dryness of the mainly salivary and lacrimal glands such as the mouth, eyes, nose, larynx, and vagina. The disease overwhelmingly affects middle aged women. These women have symptoms of decreased lacrimal and salivary gland function which usually precede involvement of other exocrine glands such as the upper airway, the gastrointestinal tract and the external genitalia (dyspareunia). Although genital tract symptoms are common in patients with sjogren, such as vulvar and vaginal dryness, dyspareunia, and pruritus, their pelvic floor health and functions have been rarely evaluated. Objectives: The aim of study was investigation of pelvic floor and sexual dysfunction in patients with SS. Methods: 23 patients with SS with an average age of 49.00±8.71 were included in the study. Pelvic floor dysfunction of patients with SS were evaluated by the Pelvic Floor Impact Questtionare-7 (PFIQ-7) and Pelvic Floor Distress Inventory-20 (PFDI-20) and sexual dysfunction were evaluated by Pelvic Organ Prolapsed/Urinary Incontinence Sexual Questionnaire (PISQ-12). Results: PFIQ-7 total score was 27.14±27.73 (UIQ-7: 17.07±17.88, CRAIQ-7: 7.43±10.14, POPIQ-7: 2.32±5.00);, PFDI-20 total score was 116.36±34.00 (POPDI-6:31.48±8.29, CRADI-8: 35.59±15.73, UDI-6:49.00±16.56) and PISQ-12 total score was 16.78±5.71. Conclusion: According to the results of the study, patients with SS had pelvic floor dysfunction and sexual dysfunction. This study showed that pelvic floor and sexual functions of patients with SS have been negatively affected. Therefore these functions need to be routinely assessed by health professionals. Further studies need to recommend pelvic health physiotherapy and educational programme about pelvic floor dysfunction.